Carr Financial Group’s Coherus Oncology CHRS Stock Holding History

Carr Financial Group’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.3K	Hold	35,195	–	–	0.01%	181
2026 Q1	$59.5K	Hold	35,195	–	–	0.02%	173
2025 Q4	$50K	Hold	35,195	–	–	0.01%	185
2025 Q3	$57.7K	Hold	35,195	–	–	0.02%	188
2025 Q2	$25.7K	Hold	35,195	–	–	0.01%	187
2025 Q1	$28.4K	Hold	35,195	–	–	0.01%	175
2024 Q4	$48.6K	Hold	35,195	–	–	0.02%	184
2024 Q3	$36.6K	Hold	35,195	–	–	0.01%	196
2024 Q2	$60.9K	Hold	35,195	–	–	0.02%	185
2024 Q1	$84.1K	Hold	35,195	–	–	0.03%	178
2023 Q4	$117K	Buy	+35,195	New	+$94.3K	0.04%	166

Other funds holding CHRS

TGY2IT

Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Carr Financial Group's CHRS Position: Q2 2026 in Review

Carr Financial Group held its Coherus Oncology (CHRS) position steady in Q2 2026 at 35,195 shares worth $49.3K. The position accounts for 0.01% of the portfolio, ranked #181.

Carr Financial Group first reported a position in CHRS in Q4 2023 and has held it in 11 quarters since. The position peaked at $117K in Q4 2023. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

Carr Financial Group held 35,195 shares of Coherus Oncology worth $49.3K as of Q2 2026.
Carr Financial Group left its Coherus Oncology share count unchanged in Q2 2026.
Coherus Oncology made up 0.01% of Carr Financial Group's portfolio in Q2 2026, its #181 holding.
Carr Financial Group first reported a position in Coherus Oncology in Q4 2023 and has held it in 11 quarters since.
Carr Financial Group's Coherus Oncology position peaked at $117K in Q4 2023.
147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Carr Financial Group's 13F filing for Q2 2026, filed 6 Aug 2026.